查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402029

2030 年代孕市场预测：按类型、年龄层、技术、最终用户和地区分類的全球分析

Surrogacy Market Forecasts to 2030 - Global Analysis By Type, Age Group, Technology, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC的数据，2023年全球代孕市场规模为2.1034亿美元，预计到2030年将达到3.6282亿美元，预测期内复合年增长率为8.1%。

在生殖医学中，称为代孕，代理孕母代表另一个人或一对夫妇携带和分娩孩子。当由于健康状况而难以或不可能正常怀孕时，可以使用这种辅助生殖技术。代孕主要有两种型态：妊娠代孕，即代孕母亲透过体外受精（IVF）受精的胚胎怀孕；传统代孕，即代孕母亲提供卵子。

根据世界卫生组织（WHO）的报告，开发中国家有四分之一的夫妇患有不孕症。此外，全世界每年有 6,000 至 8,000 万对夫妇遭受不孕不育的困扰，光是印度就有 1,500 至 2,000 万对夫妇 (25%) 遭受不孕不育的困扰。

意识提升和接受度

社会对不孕症问题的认识提高和公开对话已导致代孕被视为合法且富有同情心的生殖选择。此外，倡导团体、网路论坛和教育计画正在帮助消除围绕代孕的耻辱，并为与不孕症作斗争的单身和夫妇创造更鼓励的氛围。

代理人的数量是有限的。

由于缺乏愿意且合适的代孕妈妈，代孕市场受到严重限制。难以找到符合医疗和心理要求的合适候选人可能会延迟匹配预期父母和代孕妈妈的过程。此外，社会耻辱、对潜在健康风险的担忧以及代孕程序的严格性也可能导致这种短缺。

生殖医学的技术进步

由于生殖医学技术的不断进步，包括基因检测、胚胎筛检和人工生殖技术的进步，代孕市场存在着巨大的机会。此外，成功率的提高、胚胎选择的改进以及更先进的生育治疗的开发使得代孕成为寻求代孕的父母更可行且更具成本效益的选择。

监管变化和法律不确定性

不同司法管辖区关于代孕的不同法律体制为代孕产业带来了严重风险。此外，法律的快速变化和法律的模糊性给代孕组织、意向父母和代孕妈妈带来了困难，并可能导致法律衝突和併发症，从而阻碍代孕协议的有序进展。

COVID-19 的影响：

COVID-19大流行对代孕市场产生了重大影响，为辅助生殖技术领域带来了困难和破坏。大流行带来的旅行限制和关闭阻碍了参与代孕过程的意向父母、代孕妈妈和医疗保健提供者的国际流动。持续的健康问题、诊所关闭和生育治疗的延误导致代孕手术暂时减少。此外，大流行的经济影响可能会影响父母接受代孕服务的能力。

妊娠代孕产业预计将在预测期内成为最大的产业

作为辅助生殖技术中最常见和首选的方法，妊娠代孕占据了最大的市场份额。在怀孕代孕中，卵子和精子由捐赠者或预期父母提供，胚胎是透过体外受精（IVF）产生的。这种方法透过切断代孕妈妈和孩子之间的遗传联繫，提供了更多的情感和法律清晰度。此外，生殖技术的进步使妊娠代孕被广泛认为是一个更可控和可预测的过程。

预计不孕症诊所领域在预测期内将出现最高的复合年增长率。

在代孕市场中，复合年增长率最高的细分市场是生育诊所。这些专业诊所提供最先进的生殖服务，对于解决日益增加的不孕症发病率至关重要。我们的生育诊所提供全面的诊断评估、最先进的辅助生殖技术 (ART)（包括体外受精 (IVF)）以及根据每位患者和夫妇的需求量身定制的个人化治疗方案。此外，社会对辅助生殖技术的接受度不断提高，人们对不孕症问题的认识不断提高，对生育诊所提供的服务的需求也随之增加。

比最大的地区

北美占据全球代孕市场的最大份额。该地区（包括美国和加拿大）由于先进的医疗保健系统、高意识和对生殖技术的大量投资而占据主导地位。不孕症服务的高需求部分是由于文化上对辅助生殖技术（ART）的接受度以及不孕不育问题的普遍存在。此外，由于主要生育诊所、研究机构和技术开发的集中，北美作为生殖医疗产业主要参与者的地位进一步得到加强。

复合年增长率最高的地区：

在全球代孕市场中，亚太地区的复合年增长率最高。不孕症盛行率上升以及人们对辅助生殖技术（ART）的理解和接受程度不断提高，推动了亚太地区对生殖健康服务的需求。该地区的快速增长归因于多种因素，包括生活方式的演变、计划生育的延迟以及生殖健康的改善。此外，亚太国家不孕症治疗的扩大和医疗基础设施的改善正在支持市场成长。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球代孕市场：依类型

  • 妊娠代孕
  • 传统代孕
  • 其他类型

第六章 全球代孕市场：依年龄段

  • 35岁以下
  • 35-37岁
  • 38-39岁
  • 40-42岁
  • 43-44岁
  • 44岁以上

第七章 全球代孕市场：依技术分类

  • 子宫内人工授精 (IUI)
  • 体外受精（IVF）
    • 经典/标准 IVF
    • 胞浆内单一精子注射 (ICSI)
  • 其他技术

第八章 全球代孕市场：依最终用户分类

  • 医院
  • 不孕不育诊所
  • 其他最终用户

第九章 全球代孕市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Extraordinary Conceptions
  • Boston IVF
  • Growing Generations LLC
  • IVIRMA Global
  • Max Healthcare
  • New Hope Fertility Center
  • Bourn Hall International
  • Houston Fertility Center
  • Circle Surrogacy & Egg Donation
  • Nova Ivi Fertility
  • Ovation Fertility
  • Scanfert Clinic
  • Care Fertility Group
Product Code: SMRC24549

According to Stratistics MRC, the Global Surrogacy Market is accounted for $210.34 million in 2023 and is expected to reach $362.82 million by 2030 growing at a CAGR of 8.1% during the forecast period. A surrogate woman bears and gives birth to a child on behalf of another person or couple in a reproductive arrangement known as surrogacy. When conventional conception is difficult or impossible due to medical conditions, this assisted reproductive technology is used. Moreover, the two main forms of surrogacy are gestational surrogacy, in which the surrogate carries an embryo fertilized by in vitro fertilization (IVF), usually using the genetic material of the intended parents or donors, and traditional surrogacy, in which the surrogate contributes her egg.

According to a report by the World Health Organization (WHO), one in four couples in developing nation's experiences infertility. Additionally, 60-80 million couples worldwide suffer from infertility each year, with 15-20 million (25%) residing in India alone.

Market Dynamics:

Driver:

Raising awareness and acceptance

Growing awareness campaigns and a more candid conversation about fertility issues in society are supporting surrogacy's growing acceptance as a legal and compassionate reproductive option. Additionally, advocacy groups, internet forums, and educational programs help dispel the stigmas surrounding surrogacy and create a more encouraging atmosphere for single people and couples dealing with infertility.

Restraint:

Limited number of surrogates available

The surrogacy market is significantly constrained by the lack of willing and suitable surrogates. The process of matching intended parents with surrogates can be delayed when appropriate candidates who fulfill both medical and psychological requirements are difficult to find. Furthermore, social stigmas, worries about potential health hazards, or the rigorous requirements of the surrogacy procedure could all contribute to this shortage.

Opportunity:

Technological progress in reproductive health

Significant opportunities exist for the surrogacy market as a result of ongoing technological advancements in reproductive medicine, such as advances in genetic testing, embryo screening, and artificial reproductive techniques. Moreover, for intended parents, surrogacy is becoming a more practical and cost-effective option thanks to increased success rates, improved embryo selection, and the development of more advanced fertility treatments.

Threat:

Regulation changes and legal uncertainties

Diverse legal frameworks for surrogacy across different jurisdictions present a serious risk to the surrogacy industry. Additionally, swift alterations in laws or legal ambiguities could pose difficulties for surrogacy organizations, intended parents, and surrogates, resulting in possible legal conflicts and complications that could hinder the orderly advancement of surrogacy agreements.

COVID-19 Impact:

The COVID-19 pandemic has had a major effect on the surrogacy market and brought difficulties and disturbances to the assisted reproductive sector. Travel restrictions and lockdowns brought on by the pandemic have hindered the international mobility of intended parents, surrogates, and healthcare providers participating in the surrogacy process. There has been a brief decrease in surrogacy procedures due to ongoing health concerns, clinic closures, and delays in fertility treatments. Furthermore, the pandemic's effects on the economy could have an impact on intended parents' ability to afford surrogacy services.

The Gestational Surrogacy segment is expected to be the largest during the forecast period

As the most common and favored method of assisted reproduction, gestational surrogacy commands the largest share of the market. When a person is used in a gestational surrogacy, their eggs and sperm from donors or the intended parents are used to create an embryo through in vitro fertilization (IVF). This approach provides more emotional and legal clarity by severing genetic ties between the surrogate and the child. Moreover, reproductive technology advancements have made gestational surrogacy more widely recognized as a more controlled and predictable process.

The Fertility Clinics segment is expected to have the highest CAGR during the forecast period

In the surrogacy market, the segment with the highest CAGR is fertility clinics. These specialist clinics, which provide a range of cutting-edge reproductive services, are essential in tackling the growing incidence of infertility. Fertility clinics offer thorough diagnostic evaluations, state-of-the-art assisted reproductive technologies (ART), including in vitro fertilization (IVF), and individualized treatment programs made to meet each patient's or couple's specific needs. Additionally, the demand for the services provided by fertility clinics has increased due to rising societal acceptance of ART and increased awareness of fertility issues.

Region with largest share:

In the global surrogacy market, North America holds the largest share. Because of its sophisticated healthcare system, high level of awareness, and large investments in reproductive technologies, this region-which includes the United States and Canada-dominates. The high demand for fertility services is partly due to the cultural acceptance of assisted reproductive technologies (ART) and the prevalence of infertility problems. Moreover, North America's status as a major player in the reproductive healthcare industry is further cemented by the region's concentration of top fertility clinics, research institutes, and technological developments in the field.

Region with highest CAGR:

In terms of the global market for surrogacy, the Asia-Pacific region has the highest CAGR. The demand for reproductive services in Asia-Pacific is driven by the rising prevalence of infertility as well as increased understanding and acceptance of assisted reproductive technologies (ART). The region's rapid growth is caused by a number of factors, including evolving lifestyles, postponing family planning, and improvements in reproductive health. Furthermore, expanding fertility treatments and better healthcare infrastructure in Asia-Pacific nations support the market's growth.

Key players in the market:

Some of the key players in Surrogacy market include Extraordinary Conceptions, Boston IVF, Growing Generations LLC, IVIRMA Global, Max Healthcare, New Hope Fertility Center, Bourn Hall International, Houston Fertility Center, Circle Surrogacy & Egg Donation, Nova Ivi Fertility, Ovation Fertility, Scanfert Clinic and Care Fertility Group.

Key Developments:

In November 2023, IVI RMA, one of the largest reproductive medicine groups in the world, has signed a definitive agreement to acquire the North American Operations of Eugin Group, consisting of the Boston IVF fertility network and Toronto-based TRIO, from healthcare group Fresenius. The strategic additions will grow IVI RMA to become a leading fertility group in North America and reinforce the company's commitment to providing evidence-based fertility solutions with the greatest chance of success to the greatest number of patients.

In October 2023, Boston IVF, a renowned leader in fertility research and patient care since its establishment in 1986, is proud to announce its substantial participation in the 2023 American Society for Reproductive Medicine (ASRM) Scientific Congress and Expo. This prestigious annual event, in New Orleans, Louisiana, from October 14-18, brought together global experts to share groundbreaking advancements in technology, treatments, and patient care in reproductive medicine.

Types Covered:

  • Gestational Surrogacy
  • Traditional Surrogacy
  • Other Types

Age Groups Covered:

  • Below 35 Years
  • 35-37 Years
  • 38-39 Years
  • 40-42 Years
  • 43-44 Years
  • Over 44 Years

Technologies Covered:

  • Intrauterine Insemination (IUI)
  • In-vitro Fertilization (IVF)
  • Other Technologies

End Users Covered:

  • Hospitals
  • Fertility Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Surrogacy Market, By Type

  • 5.1 Introduction
  • 5.2 Gestational Surrogacy
  • 5.3 Traditional Surrogacy
  • 5.4 Other Types

6 Global Surrogacy Market, By Age Group

  • 6.1 Introduction
  • 6.2 Below 35 Years
  • 6.3 35-37 Years
  • 6.4 38-39 Years
  • 6.5 40-42 Years
  • 6.6 43-44 Years
  • 6.7 Over 44 Years

7 Global Surrogacy Market, By Technology

  • 7.1 Introduction
  • 7.2 Intrauterine Insemination (IUI)
  • 7.3 In-vitro Fertilization (IVF)
    • 7.3.1 Classical/Standard IVF
    • 7.3.2 Intracytoplasmic Sperm Injection (ICSI)
  • 7.4 Other Technologies

8 Global Surrogacy Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Fertility Clinics
  • 8.4 Other End Users

9 Global Surrogacy Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Extraordinary Conceptions
  • 11.2 Boston IVF
  • 11.3 Growing Generations LLC
  • 11.4 IVIRMA Global
  • 11.5 Max Healthcare
  • 11.6 New Hope Fertility Center
  • 11.7 Bourn Hall International
  • 11.8 Houston Fertility Center
  • 11.9 Circle Surrogacy & Egg Donation
  • 11.10 Nova Ivi Fertility
  • 11.11 Ovation Fertility
  • 11.12 Scanfert Clinic
  • 11.13 Care Fertility Group

List of Tables

  • Table 1 Global Surrogacy Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 4 Global Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 5 Global Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 6 Global Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 7 Global Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 8 Global Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 9 Global Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 10 Global Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 11 Global Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 12 Global Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 13 Global Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 14 Global Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 15 Global Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 16 Global Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 17 Global Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 18 Global Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 19 Global Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 20 Global Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 21 Global Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 22 Global Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 23 North America Surrogacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 25 North America Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 26 North America Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 27 North America Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 28 North America Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 29 North America Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 30 North America Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 31 North America Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 32 North America Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 33 North America Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 34 North America Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 35 North America Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 36 North America Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 37 North America Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 38 North America Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 39 North America Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 40 North America Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 41 North America Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 North America Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 43 North America Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 44 North America Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 45 Europe Surrogacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 47 Europe Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 48 Europe Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 49 Europe Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 50 Europe Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 51 Europe Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 52 Europe Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 53 Europe Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 54 Europe Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 55 Europe Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 56 Europe Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 57 Europe Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 58 Europe Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 59 Europe Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 60 Europe Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 61 Europe Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 62 Europe Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 63 Europe Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 64 Europe Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 65 Europe Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 66 Europe Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 67 Asia Pacific Surrogacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 69 Asia Pacific Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 70 Asia Pacific Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 71 Asia Pacific Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 72 Asia Pacific Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 73 Asia Pacific Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 74 Asia Pacific Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 75 Asia Pacific Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 76 Asia Pacific Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 77 Asia Pacific Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 78 Asia Pacific Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 79 Asia Pacific Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 80 Asia Pacific Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 81 Asia Pacific Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 82 Asia Pacific Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 83 Asia Pacific Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 84 Asia Pacific Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 85 Asia Pacific Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 86 Asia Pacific Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 87 Asia Pacific Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 88 Asia Pacific Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 89 South America Surrogacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 91 South America Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 92 South America Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 93 South America Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 94 South America Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 95 South America Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 96 South America Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 97 South America Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 98 South America Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 99 South America Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 100 South America Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 101 South America Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 102 South America Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 103 South America Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 104 South America Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 105 South America Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 106 South America Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 107 South America Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 108 South America Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 109 South America Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 110 South America Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 111 Middle East & Africa Surrogacy Market Outlook, By Country (2021-2030) ($MN)
  • Table 112 Middle East & Africa Surrogacy Market Outlook, By Type (2021-2030) ($MN)
  • Table 113 Middle East & Africa Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
  • Table 114 Middle East & Africa Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
  • Table 115 Middle East & Africa Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 116 Middle East & Africa Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 117 Middle East & Africa Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
  • Table 118 Middle East & Africa Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
  • Table 119 Middle East & Africa Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
  • Table 120 Middle East & Africa Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
  • Table 121 Middle East & Africa Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
  • Table 122 Middle East & Africa Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
  • Table 123 Middle East & Africa Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
  • Table 124 Middle East & Africa Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
  • Table 125 Middle East & Africa Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
  • Table 126 Middle East & Africa Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
  • Table 127 Middle East & Africa Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 128 Middle East & Africa Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 129 Middle East & Africa Surrogacy Market Outlook, By End User (2021-2030) ($MN)
  • Table 130 Middle East & Africa Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 131 Middle East & Africa Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 132 Middle East & Africa Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)